Travere Therapeutics Inc (NASDAQ:TVTX)

28.50
Delayed Data
As of Nov 30
 +0.03 / +0.11%
Today’s Change
12.75
Today|||52-Week Range
33.09
+4.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues99.9M133.6M154.9M164.2M
 
 
 
 
 
Cost of Goods Sold2.0M4.6M3.6M4.9M
 
 
 
 
 
Depreciation And Amortization13.4M16.1M17.8M18.7M
 
 
 
 
 
 
Operating ExpensesGross Income84.5M112.9M133.5M140.7M
 
 
 
 
 
General Expenses116.7M147.5M161.7M209.4M
 
 
 
 
 
Research And Development49.7M70.5M77.8M122.8M
 
 
 
 
 
Total Operating Expenses132.2M168.2M183.1M232.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-32.3M-34.6M-28.2M-68.7M
 
 
 
 
 
Extraordinary Credit15.5M1.7M0.00242.0K
 
 
 
 
Extraordinary Charge-55.9M-23.6M-30.1M-28.6M
 
 
 
 
 
Interest Expense On Debt10.6M2.7M1.9M9.8M
 
 
 
 
 
Other Expenses188.8M-264.0K1.1M-474.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income105.5M-57.6M-58.4M-101.9M
 
 
 
 
 
Income Taxes-11.8M-9.7M-1.4M-811.0K
 
 
 
 
 
Net Income117.2M-47.9M-59.7M-102.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.6M37.0M38.8M40.4M
 
 
 
 
 
Shares To Calculate EPS Diluted37.6M38.3M38.8M40.4M
 
 
 
 
 
 
Earnings Per ShareEPS$3.17-$1.29-$1.54-$2.54
 
 
 
 
 
EPS Diluted$3.17-$1.29-$1.54-$2.54